New York Accuses Insys of Deceptively Marketing Opioid New York Accuses Insys of Deceptively Marketing Opioid

Insys Therapeutics Inc ' s legal woes deepened on Thursday as New York ' s attorney general filed a lawsuit seeking at least $75 million from the company, which he said deceptively promoted a fentanyl-based cancer pain medicine for unsafe uses.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news